Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Rabeprazole"”.

  1. Preparation and evaluation of oral multiparticulate formulations of acid- labile drugs

    … drugs, using ilaprazole, lansoprazole and rabeprazole sodium as model drugs. The influence of drug solubility and core type on drug layering, swelling, acid resistance, and drug release of the delayed-release pellets and pellet-tablets was investigated using lansoprazole and rabeprazole …

    fu-berlin Repository record for Preparation and evaluation of oral multiparticulate formulations of acid- labile drugs (opens in a new tab)

  2. The effects of CTDSP1 on topoI degradation and cellular resistance to topoI inhibitors chemotherapy treatment

    … and HCT116, by silencing with siRNA and using Rabeprazole (a pharmacological agent known to inhibit CTDSP1). Inhibition of CTDSP1 phosphatase activity resulted in greater phosphorylation of DNA-PKcs and increased the rate of topoI degradation in the cells in response to CPT. Cellular resistance …

    bu Repository record for The effects of CTDSP1 on topoI degradation and cellular resistance to topoI inhibitors chemotherapy treatment (opens in a new tab)

  3. AN IN VITRO INVESTIGATION INTO THE MECHANISM OF THE CLINICALLY RELEVANT DRUG-DRUG INTERACTION BETWEEN OMEPRAZOLE OR ESOMEPRAZOLE AND CLOPIDOGREL

    … esomeprazole, lansoprazole, pantoprazole, and rabeprazole) with clopidogrel to decrease the risk of upper gastrointestinal bleeding. This practice was formalized for high risk patients by the American Heart Association (and others) in 2008. By 2009, numerous publications described an unexpected …

    ku Repository record for AN IN VITRO INVESTIGATION INTO THE MECHANISM OF THE CLINICALLY RELEVANT DRUG-DRUG INTERACTION BETWEEN OMEPRAZOLE OR ESOMEPRAZOLE AND CLOPIDOGREL (opens in a new tab)

  4. Protonų siurblio inhibitorių suvartojimo tyrimas Lietuvoje 2022 metais /

    … number of prescriptions issued in 2022 was for rabeprazole and lansoprazole (1.54% each). Although the population group aged 65 and older is not the largest in Lithuania, it is still the main group in PPI consumption. In the children's age group (0-17), PPI consumption was the lowest. The total …

    vilnius Repository record for Protonų siurblio inhibitorių suvartojimo tyrimas Lietuvoje 2022 metais / (opens in a new tab)

  5. Potential Effects of Proton Pump Inhibitors on Periodontal Disease: A Systematic Review

    … and animal studies. Only FDA-approved PPIs (rabeprazole, lansoprazole, pantoprazole, omeprazole, dexlansoprazole, esomeprazole) were included. Risk of bias was performed using the OHAT and QUIN assessment tools. Results: A total of 260 studies were included. Primary effects of PPIs involved …

    buffalo Repository record for Potential Effects of Proton Pump Inhibitors on Periodontal Disease: A Systematic Review (opens in a new tab)

  6. Validação de métodos analíticos e estudo da estabilidade de rabeprazol sódico

    Neste trabalho, foram desenvolvidos e validados métodos qualitativos e quantitativos para o controle de qualidade de rabeprazol sódico, um inibidor da bomba de prótons. O fármaco apresenta eficácia comprovada na cicatrização, alívio de sintomas e prevenção de recidivas de úlceras pépticas e doença …

    brazil-ufrgs Repository record for Validação de métodos analíticos e estudo da estabilidade de rabeprazol sódico (opens in a new tab)